Method for high-throughput RNA sequencing in single cells developed
A new method named scifi-RNA-seq marks the RNA of cells with specific barcodes, enabling the sequencing of many cells at the same time.
List view / Grid view
A new method named scifi-RNA-seq marks the RNA of cells with specific barcodes, enabling the sequencing of many cells at the same time.
Learn about a practical, high-throughput method for validating the target-specificity of antibodies for the application of western blot.
Using electrochemical detection and redox labels, researchers have created a new, faster method to sequence DNA.
Researchers have measured the gene expression of healthy and cancerous single cells from breast tissue, creating an 'RNA atlas'.
Solutions to aid understanding of cellular and molecular pathways in diabetes and translate these findings into prevention and treatment strategies.
A spatial atlas of early-stage lung cancer has been compiled at single-cell resolution, revealing new therapeutic targets.
Gain more insight into immune-tumor interactions and learn how antibody detection techniques like multiplexing is advancing immunotherapies.
Scientists have created a new nanopore sequencing platform that can detect the presence of the nucleobases of DNA.
Using single-cell sequencing technology, researchers have gained insight into the interactions of dental pulp and periodontal cells of teeth.
5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
An algorithm which continuously processes new data has been developed to allow researchers to access and analyse single-cell sequencing information.
Discover how a new ELISA against S1-RBD for COVID-19 seroconversion detection can accelerate discovery to facilitate vaccine breakthroughs.
The isolation of microbial DNA is a key prerequisite for determining the microbiome profile of each body habitat.
Magnetic separation with Dynabeads helps ensure that the isolated cells are not affected by passage through a dense column.
Professor Martin Michaelis and Dr Mark Wass explain why new SARS-CoV-2 variants are emerging around the world and how vaccines will have to adapt in response.